Why Attendees Chose to Attend the 8th CRISPR AgBio Congress

This was the premier meeting where technical advances and commercial strategies converge to accelerate CRISPR-enabled crop innovation. The summit saw deep dives into next-gen nucleases, AI-powered trait discovery, and regulatory clarity across global markets.

About event - 8th CRISPR AgBio Congress 2026

The Sessions Everyone Loved!

Commercial Strategies & Investment Insights

Gained practical guidance on attracting the right partners and investors, shaping development to meet regulatory and market expectations, and building pipelines positioned for long-term success in gene-edited crops.

Heard from:

  • Mihir Kekre, Head of Commercial Partnerships, Tropic Biosciences
  • Matthew Begemann, Senior Director, R&D, Confluence Genetics
  • Martin Slayne, Vice President, Global Scientific & Regulatory Affairs, Ingredion
Next-Generation Editing & Delivery Platforms

Explored cutting-edge CRISPR technologies and delivery breakthroughs that unlock precision, scalability, and efficiency for complex crop traits. Learnt how innovators are overcoming genotype dependency and accelerating design-build-test cycles to reduce time-to-market.

Insights from:

  • Jeff Sander, Head of Genome Editing, Corteva Agriscience
  • Matt DiLeo, Vice President, R&D, Elo Life Systems
  • Shira Corem, Vice President, R&D, BetterSeeds
  • Gagan Sidhu, Chief Technology Officer, Meiogenix
Unlocking Consumer Acceptance & Market Advantage

Understood how leading brands and technology providers are shaping consumer trust and positioning gene-edited products for success. Explored real-world insights on labeling, transparency, and messaging that earn premiums and accelerate adoption.

Speakers:

  • Lauren Scolnic, Associate Director, Communications, Pairwise
  • Carl Jones, Director, Plant Sciences, Mars Advanced Research Institute
Regulatory Focus Day

Kicked off the congress with a dedicated pre-conference day on Global Regulatory Frameworks. Gained actionable strategies to navigate diverse approval pathways across the U.S., EU, Latin America, and Africa.

Key sessions included:

  • Christine Shyu, Bayer Crop Science: Harmonizing global regulatory frameworks
  • Francisca Castillo, NeoCrop Technologies: Lessons from CRISPR approvals in Chile and Argentina
  • Anindya Bandyopadhyay, CIMMYT: Optimizing innovation and compliance for competitive advantage
  • Vishnutej Ellur, Syngenta: Protein characterization strategies to strengthen submissions

Event Highlights

Global Regulations & IP Focus Day

Navigated evolving policies in the US, Canada, EU & LATAM.

AI in AgBio

Explored machine learning applications for faster, more accurate trait targeting.

Driving Consumer Acceptance Panel

Learnt trust-building strategies from leading CPGs and growers.

Commercialization Strategies

Lessons learned from successful product launches.

What You Missed

  • 100+ Global Leaders in CRISPR AgBio Innovation
  • 3 Days of Technical Breakthroughs & Commercial Strategies
  • Dedicated Regulatory Focus Day for Global Market Access
  • Networking Designed for Partnerships & Capital Generation
  • Consumer Perspective Panels & Industry Leader Fireside Chats
Event Guide Banner - 8th CRISPR AgBio Congress 2026

Attending Companies Included

Explore Agenda - 8th CRISPR AgBio Congress 2026
Explore the 2026 Agenda

Discover cutting-edge sessions on CRISPR, AI, and commercialization strategies.

Partner with us - 8th CRISPR AgBio Congress 2026
Partner With Us

Position your brand at the center of AgBio innovation and deal-making.

AgBio Experts - 8th CRISPR AgBio Congress 2026
Join the AgBio Community

Network with decision-makers shaping the future of sustainable agriculture.